Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC, Middlesex, NJ 08846, NDC 64720-215-10
Published April 27, 2016 · Recall initiated: March 14, 2016
Summary
FDA records drug Class II recall D-0826-2016, published April 27, 2016 and initiated March 14, 2016. Recalling firm: Impax Laboratories, Inc.; Status: Terminated; Reported quantity: 18,936 bottles; Lot: Lot #: 112565, Exp 03/17; 113458, Exp 08/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Impax Laboratories, Inc.
- Distributor
- Nationwide
- Lot
- Lot #: 112565, Exp 03/17; 113458, Exp 08/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, RxDecember 28, 2016
- FDADextroamphetamine Sulfate Tablets USP, 10 mg, 100-count bottle, Rx only, Manufactured and Distributed by:April 27, 2016
- FDADextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, ILApril 27, 2016
- FDADextrose Injection, USP, 50%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, ILApril 27, 2016
- FDAFenofibrate Capsules (Micronized) 134 mg, 500-count bottle, Rx Only, Distributed by Impax Generics, Hayward,April 20, 2016
- FDACatalog Number: 900946 STRABISMUS SURGICAL PACK Used by medical staff to perform surgical procedures andApril 20, 2016
Questions about this recall
Was Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC, Middlesex, NJ 08846, NDC 64720-215-10 recalled?
Yes. FDA published recall D-0826-2016 on April 27, 2016. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter